CoChat

Small-molecule activators of RNase L with broad-spectrum antiviral activity

Open access
Thakur, Chandar S., Jha, Babal Kant, Dong, Beihua, Das Gupta, Jaydip, Silverman, Kenneth M., Mao, Hongxia, Sawai, Hiro, Nakamura, Akiko O., Banerjee, Amiya K., Gudkov, Andrei, Silverman, Robert H. · 2007 · Proceedings of the National Academy of Sciences
Cited by 124

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

RNase L, a principal mediator of innate immunity to viral infections in higher vertebrates, is required for a complete IFN antiviral response against certain RNA stranded viruses. dsRNA produced during viral infections activates IFN-inducible synthetases that produce 5′-phosphorylated, 2′,5′-oligoadenylates (2-5A) from ATP. 2-5A activates RNase L in a wide range of different mammalian cell types, thus blocking viral replication. However, 2-5A has unfavorable pharmacologic properties; it is rapidly degraded, does not transit cell membranes, and leads to apoptosis. To obtain activators of RNase L with improved drug-like properties, high-throughput screening was performed on chemical libraries by using fluorescence resonance energy transfer. Seven compounds were obtained that activated RNase L at micromolar concentrations, and structure–activity relationship studies resulted in identification of an additional four active compounds. Two lead compounds were shown to have a similar mechanistic path toward RNase L activation as the natural activator 2-5A. The compounds bound to the 2-5A-binding domain of RNase L (as determined by surface plasmon resonance and confirmed by computational docking), and the compounds induced RNase L dimerization and activation. Interestingly, the low-molecular-weight activators of RNase L had broad-spectrum antiviral activity against diverse types of RNA viruses, including the human pathogen human parainfluenza virus type 3, yet these compounds by themselves were not cytotoxic at the effective concentrations. Therefore, these RNase L activators are prototypes for a previously uncharacterized class of broad-spectrum antiviral agents.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.0700590104

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 4 references

Cited by

See all 124

Metadata

Authors
Thakur, C. S., Jha, B. K., Dong, B., Das Gupta, J., Silverman, K. M., Mao, H., Sawai, H., Nakamura, A. O., Banerjee, A. K., Gudkov, A., & Silverman, R. H.
Venue
Proceedings of the National Academy of Sciences
Published
2007-06-05
Volume
104
Issue
23
Pages
9585-9590
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2076664218
Cited by
124
References
4
FWCI
2.63
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Small-molecule activators of RNase L with broad-spectrum antiviral activity. https://app.cochat.ai/papers/10.1073/pnas.0700590104
The paper
Thakur, C. S., Jha, B. K., Dong, B., Das Gupta, J., Silverman, K. M., Mao, H., Sawai, H., Nakamura, A. O., Banerjee, A. K., Gudkov, A., & Silverman, R. H. (2007). Small-molecule activators of RNase L with broad-spectrum antiviral activity. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.0700590104

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.